A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä
Metabolic syndrome and epigenetic aging : a twin study (2024)


Föhr, T., Hendrix, A., Kankaanpää, A., Laakkonen, E. K., Kujala, U., Pietiläinen, K. H., Lehtimäki, T., Kähönen, M., Raitakari, O., Wang, X., Kaprio, J., Ollikainen, M., & Sillanpää, E. (2024). Metabolic syndrome and epigenetic aging : a twin study. International Journal of Obesity, 48(6), 778-787. https://doi.org/10.1038/s41366-024-01466-x


JYU-tekijät tai -toimittajat


Julkaisun tiedot

Julkaisun kaikki tekijät tai toimittajatFöhr, Tiina; Hendrix, Arne; Kankaanpää, Anna; Laakkonen, Eija K.; Kujala, Urho; Pietiläinen, Kirsi H.; Lehtimäki, Terho; Kähönen, Mika; Raitakari, Olli; Wang, Xiaoling; et al.

Lehti tai sarjaInternational Journal of Obesity

ISSN0307-0565

eISSN1476-5497

Julkaisuvuosi2024

Ilmestymispäivä25.01.2024

Volyymi48

Lehden numero6

Artikkelin sivunumerot778-787

KustantajaNature Publishing Group

JulkaisumaaBritannia

Julkaisun kielienglanti

DOIhttps://doi.org/10.1038/s41366-024-01466-x

Julkaisun avoin saatavuusAvoimesti saatavilla

Julkaisukanavan avoin saatavuusOsittain avoin julkaisukanava

Julkaisu on rinnakkaistallennettu (JYX)https://jyx.jyu.fi/handle/123456789/93208


Tiivistelmä

Background
Metabolic syndrome (MetS) is associated with premature aging, but whether this association is driven by genetic or lifestyle factors remains unclear.

Methods
Two independent discovery cohorts, consisting of twins and unrelated individuals, were examined (N = 268, aged 23–69 years). The findings were replicated in two cohorts from the same base population. One consisted of unrelated individuals (N = 1 564), and the other of twins (N = 293). Participants’ epigenetic age, estimated using blood DNA methylation data, was determined using the epigenetic clocks GrimAge and DunedinPACE. The individual-level linear regression models for investigating the associations of MetS and its components with epigenetic aging were followed by within-twin-pair analyses using fixed-effects regression models to account for genetic factors.

Results
In individual-level analyses, GrimAge age acceleration was higher among participants with MetS (N = 56) compared to participants without MetS (N = 212) (mean 2.078 [95% CI = 0.996,3.160] years vs. −0.549 [−1.053,−0.045] years, between-group p = 3.5E-5). Likewise, the DunedinPACE estimate was higher among the participants with MetS compared to the participants without MetS (1.032 [1.002,1.063] years/calendar year vs. 0.911 [0.896,0.927] years/calendar year, p = 4.8E-11). An adverse profile in terms of specific MetS components was associated with accelerated aging. However, adjustments for lifestyle attenuated these associations; nevertheless, for DunedinPACE, they remained statistically significant. The within-twin-pair analyses suggested that genetics explains these associations fully for GrimAge and partly for DunedinPACE. The replication analyses provided additional evidence that the association between MetS components and accelerated aging is independent of the lifestyle factors considered in this study, however, suggesting that genetics is a significant confounder in this association.

Conclusions
The results of this study suggests that MetS is associated with accelerated epigenetic aging, independent of physical activity, smoking or alcohol consumption, and that the association may be explained by genetics.


YSO-asiasanatmetabolinen oireyhtymäaineenvaihduntaikävanheneminenperimäympäristötekijätelintavatepigenetiikkakaksostutkimus

Vapaat asiasanatepigeneettinen ikääntyminen


Liittyvät organisaatiot


Hankkeet, joissa julkaisu on tehty


OKM-raportointiKyllä

VIRTA-lähetysvuosi2024

Alustava JUFO-taso3


Viimeisin päivitys 2024-03-07 klo 20:46